Sections
| Title |
|---|
| Table Of Contents |
| 1 Introduction (Page No. - 18) |
| 1.1 Objectives Of The Study |
| 1.2 Report Description |
| 1.3 Markets Covered |
| 1.4 Stakeholders |
| 1.5 Research Methodology |
| 1.5.1 Secondary Research |
| 1.5.2 Primary Research |
| 1.5.2.1 Key Data Points From Primary Sources |
| 1.5.3 Market Size Estimation Methodology |
| 1.5.4 Market Forecast |
| 1.5.5 Market Data Validation & Data Triangulation |
| 1.6 Assumptions |
| 2 Executive Summary (Page No. - 30) |
| 3 Premium Insights (Page No. - 34) |
| 4 Market Overview (Page No. - 41) |
| 4.1 Introduction |
| 4.2 Market Segmentation |
| 4.3 Market Dynamics |
| 4.3.1 Drivers |
| 4.3.1.1 Rising Incidence Of Cancer Is The Primary Driver For The Tissue Diagnostics Market |
| 4.3.1.2 Rapidly Aging Population Will Increase The Disease Burden Of Non-Communicable Diseases |
| 4.3.1.3 Increased Use Of Personalized Medicine For Cancer Will Drive The Demand For Tissue-Based Companion Diagnostic Tests |
| 4.3.1.4 Growth in The Ivd Market Will Aid The Growth Of The Tissue Diagnostics Market |
| 4.3.2 Restraints |
| 4.3.2.1 Lack Of Budget To Restrict The Growth Of The Market |
| 4.3.2.2 Stringent Regulatory Framework Acts As A Major Challenge For The Tissue Diagnostics Market |
| 4.4 Market Share Analysis |
| 4.5 Porter's Analysis |
| 4.5.1 Threat From New Entrants |
| 4.5.2 Threat From Substitutes |
| 4.5.3 Bargaining Power Of Buyers |
| 4.5.4 Bargaining Power Of Suppliers |
| 4.5.5 Competitive Rivalry Among Existing Players |
| 5 Global Tissue Diagnostics Market, By Technology (Page No. - 55) |
| 5.1 Introduction |
| 5.2 Immunohistochemistry (IHC) |
| 5.3 In Situ Hybridization (ISH) |
| 5.4 Digital Pathology and Workflow Management |
| 5.5 Special Staining |
| 6 Global Tissue Diagnostics Market, By Disease (Page No. - 68) |
| 6.1 Introduction |
| 6.2 Breast Cancer |
| 6.3 Gastric Cancer |
| 6.4 Lymphoma |
| 6.5 Prostate Cancer |
| 6.6 Non-Small Cell Lung Carcinoma (NSCLC) |
| 6.7 Other Diseases |
| 7 Global Tissue Diagnotics Market, By Product (Page No. - 85) |
| 7.1 Introduction |
| 7.2 Instruments |
| 7.3 Consumables |
| 8 Global Tissue Diagnostics Market, By End User (Page No. - 93) |
| 8.1 Introduction |
| 8.2 Hospitals |
| 8.3 Pharmaceutical Companies |
| 8.4 Research Laboratories |
| 8.5 Contract Research Organizations (CRO) |
| 8.6 Other End-Users |
| 9 Geographic Analysis (Page No. - 105) |
| 9.1 Introduction |
| 9.2 The Americas |
| 9.2.1 U.S. |
| 9.2.2 Canada |
| 9.2.3 Mexico |
| 9.2.4 Chile |
| 9.2.5 Rest Of Americas (ROA) |
| 9.3 Europe |
| 9.3.1 Germany |
| 9.3.2 France |
| 9.3.3 Italy |
| 9.3.4 Spain |
| 9.3.5 U.K. |
| 9.3.6 Rest Of Europe (ROE) |
| 9.4 BRIC |
| 9.4.1 Brazil |
| 9.4.2 China |
| 9.4.3 India |
| 9.4.4 Russia |
| 9.5 Japan |
| 9.6 Rest Of The World (ROW) |
| 10 Competitive Landscape (Page No. - 195) |
| 10.1 Introduction |
| 10.2 New Product Launches |
| 10.3 Agreements, Collaborations, Expansions, Joint Ventures and Partnerships |
| 10.4 Mergers and Acquisitions |
| 10.5 Other Developments |
| 11 Company Profiles (Business Overview, Products & Services, Key Strategy, & Recent Developments)* (Page No. - 204) |
| 11.1 Abbott Laboratories, Inc. |
| 11.2 Agilent Technologies |
| 11.3 Biogenex Laboratories |
| 11.4 Bio Sb. |
| 11.5 Cell Signalling Technology, Inc. |
| 11.6 Danaher Corporation. |
| 11.7 Life Technologies |
| 11.8 Roche |
| 11.9 Sigma Aldrich |
| 11.1 Thermo Fisher Scientific |
| *Details on Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case Of Unlisted Companies. |
| Appendix (Page No. - 251) |
| List Of Tables (97 Tables) |
| Table 1 Global Tissue Diagnostics Market, By Technology, 2011-2018 ($Million) |
| Table 2 Global IHC Market, By Geography, 2011-2018 ($Million) |
| Table 3 Global ISH Market, By Geography, 2011-2018 ($Million) |
| Table 4 Global Digital Pathology and Workflow Management Market, By Geography, 2011-2018 ($Million) |
| Table 5 Global Special Staining Market, By Geography, 2011-2018 ($Million) |
| Table 6 Global Market, By Disease, 2011-2018 ($Million) |
| Table 7 Global Breast Cancer Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 8 Global Gastric Cancer Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 9 Global Lymphoma Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 10 Global Prostate Cancer Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 11 Global NSCLC Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 12 Global Other Diseases Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 13 Global Market, By Product, 2011-2018 ($Million) |
| Table 14 Global Tissue Diagnostics Instruments Market, By Geography, 2011-2018 ($Million) |
| Table 15 Global Tissue Diagnostics Consumables Market, By Geography, 2011-2018 ($Million) |
| Table 16 Global Tissue Diagnostics Market, By End User, 2011-2018 ($Million) |
| Table 17 Global Hospitals Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 18 Global Pharmaceutical Companies Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 19 Global Academic Research Laboratories Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 20 Global CRO Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 21 Global Other End-Users Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 22 Global Tissue Diagnostics Market, By Geography, 2011-2018 ($Million) |
| Table 23 The Americas: Market, By Geography, 2011-2018 ($Million) |
| Table 24 U.S.: Market, By Technology, 2011-2018 ($Million) |
| Table 25 U.S.: Market, By Disease, 2011-2018 ($Million) |
| Table 26 U.S.: Market, By Product, 2011-2018 ($Million) |
| Table 27 U.S.: Market, By End User, 2011-2018 ($Million) |
| Table 28 Canada: Market, By Technology, 2011-2018 ($Million) |
| Table 29 Canada: Market, By Disease, 2011-2018 ($Million) |
| Table 30 Canada: Market, By Product, 2011-2018 ($Million) |
| Table 31 Canada: Market, By End User, 2011-2018 ($Million) |
| Table 32 Mexico: Market, By Technology, 2011-2018 ($Million) |
| Table 33 Mexico: Market, By Disease, 2011-2018 ($Million) |
| Table 34 Mexico: Market, By Product, 2011-2018 ($Million) |
| Table 35 Mexico: Market, By End User, 2011-2018 ($Million) |
| Table 36 Chile: Market, By Technology, 2011-2018 ($Million) |
| Table 37 Chile: Market, By Disease, 2011-2018 ($Million) |
| Table 38 Chile: Market, By Product, 2011-2018 ($Million) |
| Table 39 Chile: Market, By End User, 2011-2018 ($Million) |
| Table 40 ROA: Market, By Technology, 2011-2018 ($Million) |
| Table 41 ROA: Market, By Disease, 2011-2018 ($Million) |
| Table 42 ROA: Market, By Product, 2011-2018 ($Million) |
| Table 43 ROA: Market, By End User, 2011-2018 ($Million) |
| Table 44 Europe: Market, By Geography, 2011-2018 ($Million) |
| Table 45 Germany: Market, By Technology, 2011-2018 ($Million) |
| Table 46 Germany: Market, By Disease, 2011-2018 ($Million) |
| Table 47 Germany: Market, By Product, 2011-2018 ($Million) |
| Table 48 Germany: Market, By End User, 2011-2018 ($Million) |
| Table 49 France: Market, By Technology, 2011-2018 ($Million) |
| Table 50 France: Market, By Disease, 2011-2018 ($Million) |
| Table 51 France: Market, By Product, 2011-2018 ($Million) |
| Table 52 France: Market, By End User, 2011-2018 ($Million) |
| Table 53 Italy: Market, By Technology, 2011-2018 ($Million) |
| Table 54 Italy: Market, By Disease, 2011-2018 ($Million) |
| Table 55 Italy: Market, By Product, 2011-2018 ($Million) |
| Table 56 Italy: Market, By End User, 2011-2018 ($Million) |
| Table 57 Spain: Market, By Technology, 2011-2018 ($Million) |
| Table 58 Spain: Market, By Disease, 2011-2018 ($Million) |
| Table 59 Spain: Market, By Product, 2011-2018 ($Million) |
| Table 60 Spain: Market, By End User, 2011-2018 ($Million) |
| Table 61 U.K.: Market, By Technology, 2011-2018 ($Million) |
| Table 62 U.K.: Market, By Disease, 2011-2018 ($Million) |
| Table 63 U.K.: Market, By Product, 2011-2018 ($Million) |
| Table 64 U.K.: Market, By End User, 2011-2018 ($Million) |
| Table 65 ROE: Market, By Technology, 2011-2018 ($Million) |
| Table 66 ROE: Market, By Disease, 2011-2018 ($Million) |
| Table 67 ROE: Market, By Product, 2011-2018 ($Million) |
| Table 68 ROE: Market, By End User, 2011-2018 ($Million) |
| Table 69 BRIC: Market, By Geography, 2011-2018 ($Million) |
| Table 70 Brazil: Market, By Technology, 2011-2018 ($Million) |
| Table 71 Brazil: Market, By Disease, 2011-2018 ($Million) |
| Table 72 Brazil: Market, By Product, 2011-2018 ($Million) |
| Table 73 Brazil: Market, By End User, 2011-2018 ($Million) |
| Table 74 China: Market, By Technology, 2011-2018 ($Million) |
| Table 75 China: Market, By Disease, 2011-2018 ($Million) |
| Table 76 China: Market, By Product, 2011-2018 ($Million) |
| Table 77 China: Market, By End User, 2011-2018 ($Million) |
| Table 78 India: Market, By Technology, 2011-2018 ($Million) |
| Table 79 India: Market, By Disease, 2011-2018 ($Million) |
| Table 80 India: Market, By Product, 2011-2018 ($Million) |
| Table 81 India: Market, By End User, 2011-2018 ($Million) |
| Table 82 Russia: Market, By Technology, 2011-2018 ($Million) |
| Table 83 Russia: Market, By Disease, 2011-2018 ($Million) |
| Table 84 Russia: Market, By Product, 2011-2018 ($Million) |
| Table 85 Russia: Market, By End User, 2011-2018 ($Million) |
| Table 86 Japan: Market, By Technology, 2011-2018 ($Million) |
| Table 87 Japan: Market, By Disease, 2011-2018 ($Million) |
| Table 88 Japan: Market, By Product, 2011-2018 ($Million) |
| Table 89 Japan: Market, By End User, 2011-2018 ($Million) |
| Table 90 ROW: Market, By Technology, 2011-2018 ($Million) |
| Table 91 ROW: Market, By Disease, 2011-2018 ($Million) |
| Table 92 ROW: Market, By Product, 2011-2018 ($Million) |
| Table 93 ROW: Market, By End User, 2011-2018 ($Million) |
| Table 94 New Product Launch, 2010-2014 |
| Table 95 Agreements, Partnerships, Collaborations & Joint Ventures, 2010-2014 |
| Table 96 Mergers and Acquisitions, 2010-2014 |
| Table 97 Other Developments, 2010-2014 |
| List Of Figures (37 Figures) |
| Figure 1 Research Methodology |
| Figure 2 Market Size Estimation Methodology |
| Figure 3 Market Forecasting Model |
| Figure 4 Data Triangulation Methodology |
| Figure 5 Global Tissue Diagnostics Market By Technology, 2013 Vs. 2018 ($Million) |
| Figure 6 Global Market, By Disease, 2013 Vs. 2018 ($Million) |
| Figure 7 Global Market, By End User, 2013 Vs. 2018 ($Million) |
| Figure 8 Global Market, By Geography, 2013 Vs. 2018 ($Million) |
| Figure 9 Global Market, Geographic Analysis, 2013 ($Million) |
| Figure 10 Global Market, By Disease, 2013 |
| Figure 11 Global Market, By Disease, 2013 Vs. 2018 |
| Figure 12 Global Market, By Disease, 2011-2018 (Market Sizes & Growth Rates) |
| Figure 13 Global Market, By Technology, 2013 |
| Figure 14 Global Market, By Technology, 2013 Vs. 2018 |
| Figure 15 Global Market, By Technology, 2011-2018 (Market Sizes & Growth Rates) |
| Figure 16 Global Market, By End User, 2013 |
| Figure 17 Global Market, By End User, 2013 Vs. 2018 |
| Figure 18 Global Market, By End User, 2011-2018 (Market Sizes & Growth Rates) |
| Figure 19 Market Segmentation |
| Figure 20 Market-Drivers & Restraints |
| Figure 21 Market Share Analysis, By Key Player, 2013 |
| Figure 22 Porter's Five Forces Analysis |
| Figure 23 Global Market Segmentation, By Technology |
| Figure 24 Global Market, By Technology, 2013-2018 |
| Figure 25 Global Market Segmentation, By Disease |
| Figure 26 Global Market, By Disease, 2013-2018 |
| Figure 27 Global Market Segmentation, By End Users |
| Figure 28 Global Market, By End User, 2013-2018 |
| Figure 29 Global Market, By Region, 2013 |
| Figure 30 Key Growth Strategies, Tissue Diagnostics Market, 2010-2014 |
| Figure 31 Abbott Laboratories, Inc. Overview |
| Figure 32 Agilent Technologies Overview |
| Figure 33 Danaher Corporation. Overview |
| Figure 34 Life Technologies Overview |
| Figure 35 Roche Overview |
| Figure 36 Sigma Aldrich Overview |